Aesthetic injectables company scaling sales and medical education internationally
Evolus is a NASDAQ-listed aesthetic injectables manufacturer with a sales-led organization rapidly expanding across Europe and North America. The hiring velocity is accelerating, with 15 new roles posted in the last 30 days—70% in sales, indicating a push to grow market share in injectables. The tech stack reveals dual operational needs: Salesforce + forecasting tools for sales execution, paired with Snowflake + dbt for internal medical and scientific databases that support HCP education programs. Active projects around ITSM platform rollout and international systems integration suggest the company is scaling infrastructure faster than their legacy tools can support, with pain points explicitly flagged around scalable technology and workflow bottlenecks.
Evolus manufactures and distributes aesthetic injectables, competing in the performance beauty segment. The company operates across the United States, United Kingdom, Germany, Italy, and Austria, with headquarters in Newport Beach, California. Their business model combines direct sales (via a growing sales team) with healthcare provider education—reflected in active projects around HCP training delivery and internal medical databases. The product portfolio supports aesthetic procedures, and the company is currently streamlining operational workflows (shipping, contract tracking, forecasting) while scaling a loyalty program and improving investor engagement metrics.
Evolus uses Salesforce for CRM and sales operations, Snowflake + dbt for analytics and medical databases, Azure Entra ID + Office 365 for infrastructure, and Adobe Creative Suite (Premiere, After Effects, Photoshop) + DaVinci Resolve for media production and content management.
Evolus is headquartered in Newport Beach, California, and is a NASDAQ-listed public company (ticker: EOLS) with 201–500 employees. Founded in 2014, the company operates across five countries and is actively scaling internationally.
Evolus's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.